Literature DB >> 18005742

Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia.

Julie L McAuley1, Felicita Hornung, Kelli L Boyd, Amber M Smith, Raelene McKeon, Jack Bennink, Jonathan W Yewdell, Jonathan A McCullers.   

Abstract

Secondary bacterial pneumonia frequently claimed the lives of victims during the devastating 1918 influenza A virus pandemic. Little is known about the viral factors contributing to the lethality of the 1918 pandemic. Here we show that expression of the viral accessory protein PB1-F2 enhances inflammation during primary viral infection of mice and increases both the frequency and severity of secondary bacterial pneumonia. The priming effect of PB1-F2 on bacterial pneumonia could be recapitulated in mice by intranasal delivery of a synthetic peptide derived from the C-terminal portion of the PB1-F2. Relative to its isogenic parent, an influenza virus engineered to express a PB1-F2 with coding changes matching the 1918 pandemic strain was more virulent in mice, induced more pulmonary immunopathology, and led to more severe secondary bacterial pneumonia. These findings help explain both the unparalleled virulence of the 1918 strain and the high incidence of fatal pneumonia during the pandemic.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18005742      PMCID: PMC2083255          DOI: 10.1016/j.chom.2007.09.001

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  31 in total

1.  Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection.

Authors:  Kevin L Legge; Thomas J Braciale
Journal:  Immunity       Date:  2003-02       Impact factor: 31.745

2.  Bacterial sinusitis and otitis media following influenza virus infection in ferrets.

Authors:  Ville T Peltola; Kelli L Boyd; Julie L McAuley; Jerold E Rehg; Jonathan A McCullers
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Influenza virus neuraminidase contributes to secondary bacterial pneumonia.

Authors:  Ville T Peltola; K Gopal Murti; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2005-06-08       Impact factor: 5.226

4.  Characterization of the reconstructed 1918 Spanish influenza pandemic virus.

Authors:  Terrence M Tumpey; Christopher F Basler; Patricia V Aguilar; Hui Zeng; Alicia Solórzano; David E Swayne; Nancy J Cox; Jacqueline M Katz; Jeffery K Taubenberger; Peter Palese; Adolfo García-Sastre
Journal:  Science       Date:  2005-10-07       Impact factor: 47.728

Review 5.  Molecular pathogenesis of pneumococcal pneumonia.

Authors:  J A McCullers; E I Tuomanen
Journal:  Front Biosci       Date:  2001-08-01

6.  Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae.

Authors:  Jonathan A McCullers; Kimberly C Bartmess
Journal:  J Infect Dis       Date:  2003-03-06       Impact factor: 5.226

Review 7.  Insights into the interaction between influenza virus and pneumococcus.

Authors:  Jonathan A McCullers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

8.  Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza.

Authors:  Jonathan A McCullers
Journal:  J Infect Dis       Date:  2004-06-30       Impact factor: 5.226

9.  Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor.

Authors:  Jonathan A McCullers; Jerold E Rehg
Journal:  J Infect Dis       Date:  2002-07-10       Impact factor: 5.226

10.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

Authors:  Richard Malley; Philipp Henneke; Sarah C Morse; Michael J Cieslewicz; Marc Lipsitch; Claudette M Thompson; Evelyn Kurt-Jones; James C Paton; Michael R Wessels; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

View more
  202 in total

1.  Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82.

Authors:  Irina V Alymova; Amanda M Green; Nicholas van de Velde; Julie L McAuley; Kelli L Boyd; Hazem E Ghoneim; Jonathan A McCullers
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Influenza virus induces bacterial and nonbacterial otitis media.

Authors:  Kirsty R Short; Dimitri A Diavatopoulos; Ruth Thornton; John Pedersen; Richard A Strugnell; Andrew K Wise; Patrick C Reading; Odilia L Wijburg
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

3.  Influenza virus primes mice for pneumonia from Staphylococcus aureus.

Authors:  Amy R Iverson; Kelli L Boyd; Julie L McAuley; Lisa R Plano; Mark E Hart; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2011-01-28       Impact factor: 5.226

4.  Differential localization and function of PB1-F2 derived from different strains of influenza A virus.

Authors:  Chi-Jene Chen; Guang-Wu Chen; Ching-Ho Wang; Chih-Heng Huang; Yeau-Ching Wang; Shin-Ru Shih
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

Review 5.  Current knowledge on PB1-F2 of influenza A viruses.

Authors:  Andi Krumbholz; Anja Philipps; Hartmut Oehring; Katja Schwarzer; Annett Eitner; Peter Wutzler; Roland Zell
Journal:  Med Microbiol Immunol       Date:  2010-10-16       Impact factor: 3.402

6.  IL-1 Signaling Prevents Alveolar Macrophage Depletion during Influenza and Streptococcus pneumoniae Coinfection.

Authors:  Shruti Bansal; Vijaya Kumar Yajjala; Christopher Bauer; Keer Sun
Journal:  J Immunol       Date:  2018-01-08       Impact factor: 5.422

7.  1918 pandemic influenza virus and Streptococcus pneumoniae co-infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humans.

Authors:  Kathie-Anne Walters; Felice D'Agnillo; Zong-Mei Sheng; Jason Kindrachuk; Louis M Schwartzman; Rolf E Kuestner; Daniel S Chertow; Basil T Golding; Jeffery K Taubenberger; John C Kash
Journal:  J Pathol       Date:  2015-10-14       Impact factor: 7.996

Review 8.  Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits.

Authors:  Fatma Berri; Vuong Ba Lê; Martine Jandrot-Perrus; Bruno Lina; Béatrice Riteau
Journal:  Cell Mol Life Sci       Date:  2013-10-04       Impact factor: 9.261

9.  Molecular signatures of virulence in the PB1-F2 proteins of H5N1 influenza viruses.

Authors:  Amber M Smith; Jonathan A McCullers
Journal:  Virus Res       Date:  2013-03-14       Impact factor: 3.303

Review 10.  H5N1 pathogenesis studies in mammalian models.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Virus Res       Date:  2013-02-28       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.